Skip to main content
Clinical Trials/JPRN-UMIN000006816
JPRN-UMIN000006816
Completed
Phase 3

Prospective multicenter randomized trial on the effects of Lanthanum Carbonate in hemodialysis patients compared with Calcium Carbonate on coronary artery calcification: Landmark Subsidiary Study - Randomized trial on the effects of Lanthanum Carbonate on coronary artery calcification: Landmark-SS

andmark Study Group0 sites400 target enrollmentDecember 1, 2011

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Hemodialysis patients with hyperphosphatemia
Sponsor
andmark Study Group
Enrollment
400
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2011
End Date
May 31, 2017
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
andmark Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • \- contraindications to Ca carbonate and La carbonate \- swallowing disorders \- severe GI disorders \- history of obstructed bowels \- history of IHD/stroke within 6 months \- NYHA classification III\-IV \- severe liver dysfunction, AST or ALT greater than 3 times the upper limit of institution \- require treatment of arrthythmia \- severe malnutrition \- malignancy of any type within the last 5 years \- peritoneal dialysis patients \- pregnant or possibly pregnant women or women on lactation and plan to get pregnant within study term \- ineligible patients according to the investigator's judgment

Outcomes

Primary Outcomes

Not specified

Similar Trials